Related Experiment Videos
The management of hypertensive disease in black patients
C R Gibbs1, D G Beevers, G Y Lip
1University Department of Medicine, City Hospital, Birmingham, UK.
Insights
Hypertension management differs significantly in Black or Afro-Caribbean populations due to unique pathophysiology. Tailored treatment strategies, including specific first-line agents, are crucial for effective blood pressure control and reducing complications.
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Hypertensive disease disproportionately affects Black or Afro-Caribbean populations.
- This group experiences higher rates of complications like stroke and renal impairment.
- Existing knowledge on hypertension pathophysiology and treatment in Black patients requires continuous updates.
Purpose of the Study:
- To review the management of hypertensive disease in the Black population.
- To emphasize race-related differences in hypertension pathophysiology.
- To highlight the importance of tailored management strategies for this demographic.
Main Methods:
- Literature review focusing on ethnic differences in hypertension.
- Analysis of pathophysiological mechanisms specific to Black patients.
- Evaluation of treatment guidelines and drug efficacy in diverse populations.
Main Results:
- Black or Afro-Caribbean populations exhibit distinct pathophysiological characteristics influencing hypertension.
- Diuretics and calcium antagonists show suitability as first-line agents.
- Beta-blockers and ACE inhibitors may be less effective due to a low-renin state.
Conclusions:
- Tailored management approaches are essential for hypertensive Black patients.
- Understanding race-related pathophysiological differences informs optimal treatment selection.
- Non-pharmacological measures combined with appropriate antihypertensive agents are key.
Abstract:
The ethnic differences in the incidence, pathophysiology and management of hypertensive disease, are particularly pertinent to the Black or Afro-Caribbean populations, who have a high prevalence of hypertension and associated complications, such as strokes and renal impairment. Our understanding of the underlying pathophysiology of hypertensive disease and the optimal treatment of hypertension in Black patients continues to evolve, especially with the introduction of new drugs and the need for prognostic data in this ethnic population. We review the management of hypertensive disease in the black population, emphasizing race-related differences in the pathophysiology of hypertension and the importance of tailored management in this group of patients, including sensible application of non-pharmacological measures with effective antihypertensive agents. For example, diuretics and calcium antagonists are suitable first-line agents in black hypertensives, whilst beta-blockers and the ACE inhibitors tend to be less effective at lowering blood pressure, due to the low renin state in these patients.